NCT01492153 - NovoLet® Surveillance Study on Using Human Insulin System in Indonesia | Biotech Hunter

Enrollment

1,981

Participants

Timeline

Start Date

February 11, 2003

Primary Completion Date

September 5, 2006

Study Completion Date

September 5, 2006

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

DRUG

biphasic human insulin

NovoLet® device delivering human insulin. Selection of drug and timing of dose for each patient was at the discretion of the investigator

DRUG

isophane human insulin

NovoLet® device delivering human insulin. Selection of drug and timing of dose for each patient was at the discretion of the investigator

DRUG

human soluble insulin

NovoLet® device delivering human insulin. Selection of drug and timing of dose for each patient was at the discretion of the investigator

Trial Locations (1)

Novo Nordisk Investigational Site, Jakarta